Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV000149584 | SCV002811698 | likely pathogenic | Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome | 2022-02-25 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003422037 | SCV004117097 | pathogenic | TXNL4A-related disorder | 2023-04-28 | criteria provided, single submitter | clinical testing | The TXNL4A c.349G>T variant is predicted to result in premature protein termination (p.Glu117*). This variant was reported in the compound heterozygous state in two siblings with Burn-McKeown syndrome (Wieczorek et al 2014. PubMed ID: 25434003; Wieczorek D et al 2003. PubMed ID: 14564154). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in TXNL4A are expected to be pathogenic. This variant is interpreted as pathogenic. |
OMIM | RCV000149584 | SCV000196560 | pathogenic | Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome | 2014-12-04 | no assertion criteria provided | literature only | |
Gene |
RCV000149584 | SCV000297981 | not provided | Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome | no assertion provided | literature only |